Apogee Therapeutics (APGE) EPS (Basic) (2022 - 2026)
Apogee Therapeutics (APGE) reported EPS (Basic) of -$1.06 for Q1 2026, down 11.58% year-over-year from -$1.2 in Q1 2025, and down 2.91% quarter-over-quarter from -$1.03 in Q4 2025.
Apogee Therapeutics (APGE) EPS (Basic) (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of EPS (Basic) data on file, last reported at -$1.06 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$1.06, down 11.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.33 (down 20.28% YoY), and the FY2025 annual result was -$4.22, down 27.88% from the prior year.
- EPS (Basic) retreated to -$1.06 in Q1 2026 per APGE's latest filing, from -$1.03 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.84 in Q4 2022 and troughed at -$9.46 in Q3 2022.
- A 5-year average of -$1.61 and a median of -$1.04 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) jumped 94.61% in 2023, then plunged 271.88% in 2024.
- A 5-year view of EPS (Basic) shows it stood at $0.84 in 2022, then sank by 138.1% to -$0.32 in 2023, then sank by 271.88% to -$1.19 in 2024, then rose by 13.45% to -$1.03 in 2025, then retreated by 2.91% to -$1.06 in 2026.
- Business Quant data shows APGE's EPS (Basic) at -$1.06 in Q1 2026, -$1.03 in Q4 2025, and -$1.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Apogee Therapeutics | 6.29 Bn | 5.23 Bn | - | -1.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06 |
| Dec 31, 2025 | -1.03 |
| Sep 30, 2025 | -1.11 |
| Jun 30, 2025 | -1.13 |
| Mar 31, 2025 | -0.95 |
| Dec 31, 2024 | -1.19 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -0.32 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -3.78 |
| Mar 31, 2023 | -2.51 |
| Dec 31, 2022 | 0.84 |
| Sep 30, 2022 | -9.46 |
| Jun 30, 2022 | -1.45 |